| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/ILAR.45.2.147 |
| P698 | PubMed publication ID | 15111734 |
| P2093 | author name string | Louise D McCullough | |
| Stephanie J Murphy | |||
| Joanne M Smith | |||
| P2860 | cites work | Estrogen-astrocyte interactions: implications for neuroprotection | Q24795761 |
| Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial | Q27860743 | ||
| Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II) | Q28193306 | ||
| Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial | Q28196294 | ||
| Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group | Q29615228 | ||
| A murine model of subarachnoid hemorrhage-induced cerebral vasospasm | Q30310509 | ||
| Estrogen receptor antagonist ICI182,780 exacerbates ischemic injury in female mouse | Q30642163 | ||
| Neuroprotective effects of female gonadal steroids in reproductively senescent female rats | Q30651308 | ||
| 17-beta estradiol can reduce secondary ischemic damage and mortality of subarachnoid hemorrhage | Q30652313 | ||
| Estrogen provides neuroprotection in transient forebrain ischemia through perfusion-independent mechanisms in rats | Q30653235 | ||
| 17beta-estradiol reduces stroke injury in estrogen-deficient female animals | Q30750600 | ||
| Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in Europe: data from a multicenter multinational hospital-based registry | Q30784702 | ||
| Progesterone exacerbates striatal stroke injury in progesterone-deficient female animals | Q30868372 | ||
| Estrogen decreases infarct size after temporary focal ischemia in a genetic model of type 1 diabetes mellitus | Q30955370 | ||
| Postischemic estrogen reduces hypoperfusion and secondary ischemia after experimental stroke | Q30982945 | ||
| Estrogens decrease reperfusion-associated cortical ischemic damage: an MRI analysis in a transient focal ischemia model | Q30985069 | ||
| Ovariectomy exacerbates and estrogen replacement attenuates photothrombotic focal ischemic brain injury in rats | Q31443527 | ||
| Experimental stroke in the female diabetic, db/db, mouse | Q31811899 | ||
| Glycine antagonist (GV150526) in acute stroke: a multicentre, double-blind placebo-controlled phase II trial | Q31927320 | ||
| Estradiol protects against ischemic injury | Q31978205 | ||
| Estrogen-mediated neuroprotection after experimental stroke in male rats | Q32038461 | ||
| Postmenopausal hormone replacement therapy: scientific review | Q33184140 | ||
| In vivo animal models of cerebral vasospasm: a review | Q33848030 | ||
| Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone | Q33903744 | ||
| Neuroprotective effects of estrogens: potential mechanisms of action | Q33922344 | ||
| Estradiol protects against ischemic brain injury in middle-aged rats | Q34037103 | ||
| Cerebral ischemia and inflammation | Q34139882 | ||
| Inflammation after stroke: is it harmful? | Q34214704 | ||
| Brain damage, sex hormones and recovery: a new role for progesterone and estrogen? | Q34284874 | ||
| The rapid effects of estrogen are implicated in estrogen-mediated neuroprotection | Q34292739 | ||
| Cognitive and behavioral assessment in experimental stroke research: will it prove useful? | Q34303605 | ||
| Animal models used in identifying gender-related differences | Q34327912 | ||
| An overview of new and novel pharmacotherapies for use in traumatic brain injury | Q34434685 | ||
| Animal models of neonatal stroke | Q34468327 | ||
| Hormone replacement and the prevention of cardiovascular disease | Q34707898 | ||
| Genetic aspects of stroke: human and experimental studies | Q34762913 | ||
| Effect of estrogen on endothelial function and angiogenesis | Q34964020 | ||
| Protective effects of estrogen and selective estrogen receptor modulators in the brain | Q34976075 | ||
| Experimental animal models of intracerebral hemorrhage | Q35027677 | ||
| Animal models of focal and global cerebral ischemia | Q35090269 | ||
| Models of focal cerebral ischemia in the nonhuman primate | Q35090273 | ||
| Estrogen and progesterone as neuroprotective agents in the treatment of acute brain injuries | Q35127067 | ||
| Estrogen and selective estrogen receptor modulators: neuroprotection in the Women's Health Initiative era. | Q35141438 | ||
| Estrogen and ischemic neuroprotection: an integrated view | Q35162545 | ||
| New models of focal cerebral ischaemia | Q35565638 | ||
| Gender influences the magnitude of the inflammatory response within embolic cerebral infarcts in young rats | Q36796859 | ||
| Rodent models of cerebral ischemia | Q38735687 | ||
| Carotid ligation in gerbils. Influence of age, sex, and gonads | Q39344432 | ||
| Reduction of stroke through risk factor modification | Q39703272 | ||
| Race, sex and occlusive cerebrovascular disease: a review | Q39740153 | ||
| Stroke in a defined elderly population, 1967-1985. A less lethal and disabling but no less common disease | Q41354088 | ||
| Gonadotropin pulsations across development | Q41742044 | ||
| Testosterone increases and estradiol decreases middle cerebral artery occlusion lesion size in male rats | Q42540641 | ||
| Association of serum estrogen level and ischemic neuroprotection in female rats | Q43515322 | ||
| Neuroprotective effects of estradiol in middle-aged female rats | Q43516260 | ||
| Deleterious effect of beta-estradiol in a rat model of transient forebrain ischemia | Q43590172 | ||
| 17 beta-estradiol protects neurons from ischemic damage and attenuates accumulation of extracellular excitatory amino acids | Q43619330 | ||
| A clinical trial of estrogen-replacement therapy after ischemic stroke | Q43779426 | ||
| Are there gender differences in functional outcome after stroke? | Q43828708 | ||
| Proestrus levels of estradiol during transient global cerebral ischemia improves the histological outcome of the hippocampal CA1 region: perfusion-dependent and-independent mechanisms | Q43854048 | ||
| Identification of differentially expressed genes induced by transient ischemic stroke | Q43991145 | ||
| Estrogen is neuroprotective via an apolipoprotein E-dependent mechanism in a mouse model of global ischemia. | Q44170842 | ||
| Loss of benefit from estrogen replacement therapy in diabetic ovariectomized female rats subjected to transient forebrain ischemia | Q44212263 | ||
| Nonhuman primate models of menopause workshop | Q44257162 | ||
| Incidence of stroke and myocardial infarction in women of reproductive age. | Q45992599 | ||
| Stroke in users of low-dose oral contraceptives | Q46209283 | ||
| Sex differences in postischemic neuronal necrosis in gerbils | Q46697696 | ||
| Photothrombotic middle cerebral artery occlusion in spontaneously hypertensive rats: influence of substrain, gender, and distal middle cerebral artery patterns on infarct size | Q47281851 | ||
| Genetic and gender influences on sensitivity to focal cerebral ischemia in the stroke-prone spontaneously hypertensive rat. | Q48281152 | ||
| A prospective study of cerebral ischemia in the young. Analysis of pathogenic determinants. The National Research Council Study Group | Q48323287 | ||
| Cerebral vasodilating capacity during forebrain ischemia: effects of chronic estrogen depletion and repletion and the role of neuronal nitric oxide synthase | Q48341355 | ||
| Estrogen and stroke: a balanced analysis | Q48392861 | ||
| Estrogen-dependent modulation of rat brain ascorbate levels and ischemia-induced ascorbate loss | Q48399982 | ||
| On the relationship of brain vasculature to production of neurological deficit and morphological changes following acute unilateral common carotid artery ligation in gerbils | Q48462313 | ||
| Effects of gender and estradiol treatment on focal brain ischemia | Q48481118 | ||
| Beta-estradiol protects hippocampal CA1 neurons against transient forebrain ischemia in gerbil | Q48495853 | ||
| Gender-linked brain injury in experimental stroke | Q48554257 | ||
| Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. | Q48605497 | ||
| Sex differences in US mortality rates for stroke and stroke subtypes by race/ethnicity and age, 1995-1998. | Q48616716 | ||
| Some epidemiological aspects of stroke: mortality/morbidity trends, age, sex, race, socioeconomic status | Q48645909 | ||
| Strain and gender differences in the behavior of mouse lines commonly used in transgenic studies | Q48684813 | ||
| Current Status of the Epidemiology of Brain Infarction Associated with Occlusive Arterial Disease | Q48810183 | ||
| Survival and recurrence following stroke. The Framingham study | Q48948948 | ||
| Incidence and survival rates during a two-year period of intracerebral and subarachnoid haemorrhages, cortical infarcts, lacunes and transient ischaemic attacks. The Stroke Registry of Dijon: 1985-1989. | Q50546526 | ||
| Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence Collaboration. | Q50620117 | ||
| Menopause and risk of cardiovascular disease: the Framingham study. | Q50870268 | ||
| Depression after stroke: results of the FINNSTROKE Study. | Q50907097 | ||
| Stroke incidence and mortality correlated to stroke risk factors in the WHO MONICA Project. An ecological study of 18 populations. | Q50946088 | ||
| Stroke, disability, and dementia: results of a population survey. | Q50970204 | ||
| Ten-year trends in stroke incidence and mortality in the FINMONICA Stroke Study. | Q51034138 | ||
| Neuroprotection by Estrogens in a Mouse Model of Focal Cerebral Ischemia and in Cultured Neurons: Evidence for a Receptor-Independent Antioxidative Mechanism | Q56699187 | ||
| Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study | Q58041660 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 147-159 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | ILAR Journal | Q15756706 |
| P1476 | title | Stroke in the female: role of biological sex and estrogen | |
| P478 | volume | 45 |
| Q34826145 | A haplotype of the CYP4F2 gene is associated with cerebral infarction in Japanese men. |
| Q37240874 | A novel method for assessing sex-specific and genotype-specific response to injury in astrocyte culture |
| Q38907897 | Alterations in the corticotropin-releasing hormone (CRH) neurocircuitry: Insights into post stroke functional impairments |
| Q33693242 | Brain-derived estrogen exerts anti-inflammatory and neuroprotective actions in the rat hippocampus |
| Q37068130 | Can gender differences be evaluated in a rhesus macaque (Macaca mulatta) model of focal cerebral ischemia? |
| Q36152593 | Cerebrovascular accident (stroke) in captive, group-housed, female chimpanzees |
| Q37650744 | Complexities of oestrogen in stroke |
| Q33926708 | Dietary soy may not confound acute experimental stroke infarct volume outcomes in ovariectomized female rats |
| Q39699688 | Effects of combined estrogen and progesterone on brain infarction in reproductively senescent female rats |
| Q34471155 | Estradiol alters only GAD67 mRNA levels in ischemic rat brain with no consequent effects on GABA. |
| Q36954077 | Estradiol attenuates neuroprotective benefits of isoflurane preconditioning in ischemic mouse brain |
| Q33595388 | Estrogen attenuates ischemic oxidative damage via an estrogen receptor alpha-mediated inhibition of NADPH oxidase activation |
| Q35785178 | Estrogen neuroprotection and the critical period hypothesis |
| Q37241063 | Estrogen regulation of Dkk1 and Wnt/β-Catenin signaling in neurodegenerative disease |
| Q36377761 | Estrogens and experimental ischemic stroke: a systematic review |
| Q36425620 | Experimental animal models and inflammatory cellular changes in cerebral ischemic and hemorrhagic stroke |
| Q33580146 | Extranuclear estrogen receptors mediate the neuroprotective effects of estrogen in the rat hippocampus |
| Q81488961 | Fractal and noisy CBV dynamics in humans: influence of age and gender |
| Q48346204 | Gender differences in endothelial function and inflammatory markers along the occurrence of pathological events in stroke-prone rats |
| Q36511926 | Gender differences in neurological disease: role of estrogens and cytokines |
| Q36493849 | Gender-specific response to isoflurane preconditioning in focal cerebral ischemia |
| Q35901115 | IL-4 Is Required for Sex Differences in Vulnerability to Focal Ischemia in Mice. |
| Q36493856 | Inhalational anesthetics as neuroprotectants or chemical preconditioning agents in ischemic brain |
| Q36478937 | Inhalational anesthetics as preconditioning agents in ischemic brain |
| Q26866359 | Interactions between age, sex, and hormones in experimental ischemic stroke |
| Q37440373 | Is progesterone a candidate neuroprotective factor for treatment following ischemic stroke? |
| Q34452855 | Lack of correlation of vaginal impedance measurements with hormone levels in the rat. |
| Q36672688 | Long-term estrogen deprivation leads to elevation of Dickkopf-1 and dysregulation of Wnt/β-Catenin signaling in hippocampal CA1 neurons |
| Q37575775 | MicroRNA responses to focal cerebral ischemia in male and female mouse brain |
| Q34558344 | Middle cerebral artery occlusion model in rodents: methods and potential pitfalls |
| Q36102771 | Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications |
| Q28082190 | Non-Coding RNAs in Stroke and Neuroprotection |
| Q26859430 | Nonhuman primate models of stroke for translational neuroprotection research |
| Q92237483 | Nursing Markedly Protects Postpartum Mice From Stroke: Associated Central and Peripheral Neuroimmune Changes and a Role for Oxytocin |
| Q35882885 | Oestrogen signalling and neuroprotection in cerebral ischaemia |
| Q38988985 | Partial MHC class II constructs as novel immunomodulatory therapy for stroke |
| Q37262802 | Phenotypic changes in immune cell subsets reflect increased infarct volume in male vs. female mice |
| Q34503754 | Proline-, glutamic acid-, and leucine-rich protein 1 mediates estrogen rapid signaling and neuroprotection in the brain |
| Q42613126 | Risk factors for early primary graft dysfunction after lung transplantation: a registry study |
| Q36277715 | Role for microglia in sex differences after ischemic stroke: importance of M2 |
| Q37091609 | Role of Dickkopf-1, an antagonist of the Wnt/beta-catenin signaling pathway, in estrogen-induced neuroprotection and attenuation of tau phosphorylation |
| Q35757584 | Role of the nonhuman primate for research related to women's health |
| Q97420568 | Sex Dimorphisms in Ischemic Stroke: From Experimental Studies to Clinic |
| Q34254603 | Sex differences in microRNA expression during development in rat cortex |
| Q26801284 | Sex differences in predictors of ischemic stroke: current perspectives |
| Q37432327 | Sex differences in the immune response to experimental stroke: Implications for translational research |
| Q92608469 | Sex differences in the therapeutic effects of anti-PDL2 neutralizing antibody on stroke |
| Q55461089 | Sex-Specific Features of Microglia from Adult Mice. |
| Q38678391 | Sex-dependent difference in the relationship between adipose-tissue cholesterol efflux and estradiol concentrations in young healthy humans |
| Q93341426 | Sexual differentiation of microglia |
| Q46932918 | Shear stress and 17beta-estradiol modulate cerebral microvascular endothelial Na-K-Cl cotransporter and Na/H exchanger protein levels |
| Q89187543 | Social influences on microglial reactivity and neuronal damage after cardiac arrest/cardiopulmonary resuscitation |
| Q34980295 | Splenectomy reduces infarct volume and neuroinflammation in male but not female mice in experimental stroke |
| Q26992041 | Stroke: understanding the differences between males and females |
| Q34159170 | Testosterone exacerbates neuronal damage following cardiac arrest and cardiopulmonary resuscitation in mouse |
| Q26778249 | The Effects of Exercise on Cognitive Recovery after Acquired Brain Injury in Animal Models: A Systematic Review |
| Q39012009 | The effect of combined therapies on recovery after acquired brain injury: Systematic review of preclinical studies combining enriched environment, exercise, or task-specific training with other therapies |
| Q33368554 | The impact of gender on clinical manifestations of primary antiphospholipid syndrome |
| Q46798956 | The selective oestrogen receptor modulator, LY362321, is not neuroprotective in a rat model of transient focal ischaemia. |
| Q33618256 | Young age and low temperature, but not female gender delay ATP loss and glutamate release, and protect Purkinje cells during simulated ischemia in cerebellar slices |
Search more.